Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Waters Corporation (WAT:NYSE), powered by AI.
Waters Corporation is currently trading at $360.54. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Waters Corporation on Alpha Lenz.
Waters Corporation's P/E ratio is 33.4.
“Waters Corporation trades at a P/E of 33.4 (premium valuation) with strong ROE of 29.3%. Operating margin of 25.4% indicates strong profitability.”
Ask for details →Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.
“Waters Corporation trades at a P/E of 33.4 (premium valuation) with strong ROE of 29.3%. Operating margin of 25.4% indicates strong profitability.”
Ask for details →Waters Corporation (ticker: WAT) is a company listed on NYSE in the Healthcare sector (Diagnostics & Research). It has approximately 7,600 employees. Market cap is $21.5B.
The current price is $360.54 with a P/E ratio of 33.39x and P/B of 8.38x.
ROE is 29.28% and operating margin is 25.36%. Annual revenue is $3.2B.